Literature DB >> 9242314

Stability of essential drugs in the field: results of a study conducted over a two-year period in Burkina Faso.

F Ballereau1, T Prazuck, I Schrive, M T Lafleuriel, D Rozec, A Fisch, C Lafaix.   

Abstract

To evaluate the stability of essential drugs stored in realistic tropical conditions, we have carried out a two-year prospective study in western Burkina Faso. Twenty-seven essential drugs were stored in a rural site and a urban one where temperature and hygrometry were recorded daily. Samples of each drug were taken for further analysis to the World Health Organization Collaborative Center for the Study of Stability of Drugs in Nantes, France every three months. Quantitative analysis showed that the majority of samples suffered no significant loss of their active ingredient. In contrast, ampicillin, erythromycin, sulfaguanidine, injectable furosemide, penicillin G, trimethoprim, and chloroquine showed more than a 10% quantitative loss of their active ingredient. Thus, it is not recommended that these essential drugs be stored for more than one year in a tropical climate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242314     DOI: 10.4269/ajtmh.1997.57.31

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999.

Authors:  Lamphone Syhakhang; Cecilia Stålsby Lundborg; Björn Lindgren; Göran Tomson
Journal:  Pharm World Sci       Date:  2004-12

Review 2.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 3.  Antibiotic resistance in bacteria - an emerging public health problem.

Authors:  O O Komolafe
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

Review 4.  Antimalarial drug quality in Africa.

Authors:  A A Amin; G O Kokwaro
Journal:  J Clin Pharm Ther       Date:  2007-10       Impact factor: 2.512

5.  Characterization of "Yaa Chud" Medicine on the Thailand-Myanmar border: selecting for drug-resistant malaria and threatening public health.

Authors:  Paul N Newton; Christina Y Hampton; Krystyn Alter-Hall; Thanongsak Teerwarakulpana; Sompol Prakongpan; Ronnatrai Ruangveerayuth; Nicholas J White; Nicholas P J Day; Mabel B Tudino; Natalia Mancuso; Facundo M Fernández
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

6.  Quality of antiepileptic drugs in sub-Saharan Africa: A study in Gabon, Kenya, and Madagascar.

Authors:  Jeremy Jost; Voa Ratsimbazafy; Thu Trang Nguyen; Thuy Linh Nguyen; Hanh Dufat; Annabelle Dugay; Alassane Ba; Guilhem Sivadier; Yattussia Mafilaza; Cyril Jousse; Mounir Traïkia; Martin Leremboure; Emilie Auditeau; Adeline Raharivelo; Edgard Ngoungou; Symon M Kariuki; Charles R Newton; Pierre-Marie Preux
Journal:  Epilepsia       Date:  2018-06-12       Impact factor: 5.864

7.  Keep in a cool place: exposure of medicines to high temperatures in general practice during a British heatwave.

Authors:  Brian Crichton
Journal:  J R Soc Med       Date:  2004-07       Impact factor: 18.000

8.  Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine.

Authors:  Mathieu Verbeken; Sultan Suleman; Bram Baert; Elien Vangheluwe; Sylvia Van Dorpe; Christian Burvenich; Luc Duchateau; Frans H Jansen; Bart De Spiegeleer
Journal:  Malar J       Date:  2011-02-28       Impact factor: 2.979

Review 9.  Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries.

Authors:  I N Okeke; A Lamikanra; R Edelman
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

10.  Temperatures of storage areas in large animal veterinary practice vehicles in the summer and comparison with drug manufacturers' storage recommendations.

Authors:  Jeff D Ondrak; Meredyth L Jones; Virginia R Fajt
Journal:  BMC Vet Res       Date:  2015-10-01       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.